CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

BAJAJ HEALTHCARE LTD.

NSE : BAJAJHCAREBSE : 539872ISIN CODE : INE411U01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE418.60-5.35 (-1.26 %)
PREV CLOSE () 423.95
OPEN PRICE () 425.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2877
TODAY'S LOW / HIGH ()417.50 425.40
52 WK LOW / HIGH ()376.2 744.9
NSE419.65-4.55 (-1.07 %)
PREV CLOSE() 424.20
OPEN PRICE () 423.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 419.65 (110)
VOLUME 36083
TODAY'S LOW / HIGH() 418.00 425.95
52 WK LOW / HIGH ()378.5 745
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

Sajankumar Rameshwarlal Bajaj - Chairman Sajankumar Rameshwarlal Bajaj - Managing Director

Registered Office :

Address : 602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/ A, B-39 A/1, Road No. 23,Wagle Industrial Estate, Thane (West),
Thane Dist,
Maharashtra-401604

Phone : 022 6617400 / 401

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
27Nov Bajaj Healthcare informs about appoint
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
04Oct Bajaj Healthcare informs about press r
Bajaj Healthcare has informed that the company has received recommendati..
04Oct Bajaj Healthcare secures SEC-CDSCO nod
Bajaj Healthcare has received a positive recommendation from the Subject..
24Sep Clarification sought from Bajaj Healt
The Exchange has sought clarification from Bajaj Healthcare Ltd on Septe..
11Sep Bajaj Healthcare informs about record
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosur..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit111.09394.97
Gross Profit 159.62 460.09
Operating Profit 286.031018.31
Net Sales 1479.155426.02
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 5689.30 (1.38%)
M.Cap ( in Cr)
68024.12
Abbott India (BSE)
 28869.35 (0.15%)
M.Cap ( in Cr)
61345.35
Glaxosmithkline Phar (BSE)
 2543.10 (1.35%)
M.Cap ( in Cr)
43081.65
Wockhardt (BSE)
 1360.10 (2.16%)
M.Cap ( in Cr)
22100.56
RPG Life Sciences (BSE)
 2228.80 (1.27%)
M.Cap ( in Cr)
3686.22
Shareholding Pattern
PROMOTERS 59.19%
NON-INSTITUTION 36.7%
MUTUAL FUNDS/UTI 1.66%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
HDFC Pharma and Hea...1.42

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85712.37447.05 (0.52%)
NIFTY26186.45152.70 (0.59%)
Dow Jones 47954.99104.05 (0.22%)
Nasdaq 23578.1372.99 (0.31%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI